About 100 reports

Merganser Biotech Inc

  • Therapy
  • Blood Disease
  • Biotechnology
  • Spain
  • Smoking Prevalence
  • Pharmaceutical Registrations

The Global Human Growth Hormone Market size is expected to reach $7.1 billion by 2025, rising at a market growth of 8.3% CAGR during the forecast period. Human growth hormone (HGH), also referred to as somatotropin, is a peptide hormone that stimulates growth, helps in cell reproduction as well as regeneration in humans. It is therefore important...

  • Human Growth Hormone
  • World
  • Spain
  • Asia
  • Europe
  • APAC

Major players in the pegfilgrastim biosimilars market are Mylan, Biocon, Mundipharma, Pfizer, Sandoz, Coherus, Intas Pharmaceuticals and Fresenius Kabi. The global pegfilgrastim biosimilar market is expected to decline from $534.43 million in 2019 to $453.11 million in 2020 at a compound annual growth rate (CAGR) of -15.22%. The decline...

  • Biopharmaceutical
  • Monoclonal Antibody
  • Biosimilar
  • World
  • Spain
  • United Kingdom
  • Drug Approval

Major players in the biostimulants market are BASF, Bayer CropScience, Novozymes, Koppert Biological Systems, Verdesian Life Sciences, Lallemand Plant Care, Valagro, Syngenta, Novozymes A/S and Valagro SpA. The global biostimulants market is expected grow from $2.36 billion in 2020 to $2.88 billion in 2021 at a compound annual growth...

  • Sustainable Agriculture
  • Biotechnology
  • Italy
  • World
  • Spain
  • Europe
  • North America
  • Fresno County
  • Florida

The Europe Magnetic Beads Market would witness market growth of 12.3% CAGR during the forecast period (2020-2026). A magnetic bead is an effective tool, which is utilized to make stirring action when placed in a suitable liquid solution underneath a magnetic stirrer plate. The process of separation of DNA or RNA is a very crucial in...

  • Molecular Biology
  • Laboratory
  • Respiratory Disease
  • Immunodiagnostics
  • Marketing Research
  • Cell Therapy
  • Metal Manufacturing
  • Italy
  • Europe
  • Spain
  • France
  • Germany
  • Russia
  • United Kingdom
  • Morbidity Rate

INTRODUCTION The introduction of personalized medicine has brought about a paradigm shift within the healthcare sector. Over the years, many cases have been identified where conventional treatment options have failed to demonstrate any therapeutic benefit. It is estimated that nearly 50% of prescribed drugs / therapies...

  • Diagnostics
  • Molecular Diagnostics
  • Cancer
  • Europe
  • China
  • North America
  • Australia
  • Japan
  • United States
  • APAC
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom

“KB 105 - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Ichthyosis in 7 Major Markets. A detailed picture of the KB 105 in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period...

  • Gene Therapy
  • Research And Development
  • Clinical Trial
  • Dermatological Condition
  • Europe
  • Japan
  • World
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • United States
  • Health Expenditure

The Europe Yeast Extract Market would witness market growth of 4.5% CAGR during the forecast period (2020-2026). Yeast is an example of a eukaryotic single-celled microorganism that is classified as one of the members of the fungi kingdom. Baker’s yeast is useful in the manufacturing of ethanol production, baked products, and antibiotics...

  • Alcoholic Drink
  • Beverage
  • Marketing Research
  • Animal Feed
  • Biotechnology
  • Baker's Yeast
  • Europe
  • Spain
  • France
  • Germany
  • Russia
  • Italy
  • United Kingdom
  • Alcoholic Drink Production
  • Ethanol Production

‘Antibody-Mediated Rejection (AMR) – Market Insights, Epidemiology, and Market Forecast—2030’ report deliver an in-depth understanding of the AMR, historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The AMR market report provides current...

  • Epidemiology
  • Monoclonal Antibody
  • Transplantation
  • United States
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • Drug Approval

Europe Hemostasis Diagnostics Market, 2019-2023: France, Germany, Italy, Spain, UK--Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Instrumentation Review, Technology Trends, Opportunities for Suppliers This comprehensive five-country report contains 500 pages, 120 tables, and is designed...

  • In Vitro Diagnostic Reagent
  • Coagulation Diagnostic
  • Protein Therapy
  • Europe
  • Spain
  • Germany
  • Italy
  • France

Vivia Biotech SL - Key Competitors

  • Biotechnology
  • Spain
  • Europe
  • Community of Madrid
  • Medical Devices Sales

‘Adeno-Associated Virus (AAV) Vector Based Gene Therapy - Market Insights, Epidemiology and Market Forecast—2030’ report delivers an in-depth understanding of the AAV Vector Based Gene Therapy, historical and forecasted epidemiology as well as the AAV Vector Based Gene Therapy market trends in the United States, EU5 (Germany, France, Italy,...

  • Gene Therapy
  • United States
  • Germany
  • Spain
  • France
  • Japan
  • Italy
  • United Kingdom
  • Medical Technology Density
  • Hospital Admission

Report Details Next Generation Biologics Market Report 2018-2028: Forecasts by Market and Segments • Do you need definitive Next Generation Biologics market data? • Do you want to understand clear demarcation between next generation biologics and traditional biologics? • Next Generation Biologics and sub-segment market...

  • Biopharmaceutical
  • United States
  • World
  • Spain
  • China
  • France
  • King County
  • Japan
  • Germany
  • India
  • Italy
  • United Kingdom

##.## Feb ##: Adverum Biotechnologies Announces Completion of Dosing of First Cohort of Patients in the ADVANCE Phase ##/## Clinical Trial of ADVM-## Gene Therapy for A##AT Deficiency

  • Orthopedics
  • Clinical Trial
  • Gene Therapy
  • Clinical Research
  • Pancreatic Cancer
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • Direct Sales
  • Manufacturing Orders

Table ##: TaiGen Biotechnology Co., Ltd. - Community Acquired Pneumonia Pipeline, H##- 2018

  • Therapy
  • Anti-Infective
  • Hormone
  • Pharmaceutical
  • Biopharmaceutical
  • Protein Therapy
  • Spain
  • World
  • United States
  • Community of Madrid
  • Mortality Rate
  • Hospital Admission

Evaluation of Therapeutic Segments Including Monoclonal Antibodies, Insulin, Fusion Proteins, Interferons and Gene Therapies; Prediction of Leading National Markets (US, Japan, EU5 and BRIC); Investigation of Top Products Including Humira, Remicade, Lantus and Enbrel; and Assessment of R&D Including Sirukumab and NurOwn Report...

  • Biopharmaceutical
  • Pharmaceutical
  • Regenerative Medicine
  • Gene Therapy
  • Monoclonal Antibody
  • Japan
  • United States
  • BRIC
  • Spain
  • China
  • France
  • Germany
  • Russia
  • India
  • Italy
  • Brazil
  • United Kingdom

How will Ocrevus reshape the MS treatment landscape? A multitude of recent approvals and launches are changing the way MS is treated, but what does the future hold? Key opinion leaders (KOLs) are excited about Ocrevus’ approval in relapsing and progressive forms of the disease and Mavenclad’s European approval gives patients another...

  • Neurological Disorder
  • Neurology
  • Monoclonal Antibody
  • Europe
  • Spain
  • Germany
  • European Union

Proteomics International at world's largest biotech conference

  • Proteomics
  • In Vitro Diagnostics
  • World
  • Europe
  • Spain
  • Indonesia
  • Diabetes Prevalence
  • Medical Devices Sales

Complete report $3,850.  DataPack (test volumes, sales forecasts, supplier shares) $2,500.The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next five years. New specific...

  • Coagulation Diagnostic
  • In Vitro Diagnostic Reagent
  • Laboratory Equipment
  • Monoclonal Antibody
  • Europe
  • Japan
  • Spain
  • France
  • Germany
  • United States
  • Italy
  • United Kingdom

The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and AT III testing...

  • Coagulation Diagnostic
  • Laboratory Equipment
  • Monoclonal Antibody
  • Europe
  • Japan
  • Spain
  • France
  • Germany
  • United States
  • Italy
  • United Kingdom

The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and D-Dimer testing...

  • Coagulation Diagnostic
  • Laboratory Equipment
  • Monoclonal Antibody
  • Europe
  • Japan
  • Spain
  • France
  • Germany
  • United States
  • Italy
  • United Kingdom

The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Fibrinogen...

  • Coagulation Diagnostic
  • Biomaterial
  • Fibrin Sealants
  • Laboratory Equipment
  • Monoclonal Antibody
  • Europe
  • Japan
  • Spain
  • France
  • Germany
  • United States
  • Italy
  • United Kingdom

The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Heparin testing...

  • Coagulation Diagnostic
  • Laboratory Equipment
  • Monoclonal Antibody
  • Europe
  • Japan
  • Spain
  • France
  • Germany
  • United States
  • Italy
  • United Kingdom

The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next five years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Proteins C...

  • Coagulation Diagnostic
  • Laboratory Equipment
  • Monoclonal Antibody
  • Europe
  • Japan
  • Spain
  • France
  • Germany
  • United States
  • Italy
  • United Kingdom

The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next five years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and PT testing...

  • Coagulation Diagnostic
  • Laboratory Equipment
  • Monoclonal Antibody
  • Europe
  • Japan
  • Spain
  • France
  • Germany
  • United States
  • Italy
  • United Kingdom

How well does your Rheumatoid Arthritis medical affairs team performance compare with the rest? According to this latest survey of 150 rheumatologists across the EU5 (UK, France, Germany, Italy and Spain) the performance of rheumatoid arthritis medical affairs teams still has a way to go in some key areas. Find out what physicians...

  • Arthritis
  • Monoclonal Antibody
  • Health Care Provider
  • Europe
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • World

Roche's diagnostic products include clinical chemistry and immunoassays, molecular diagnostics, tissue diagnostics, point of care diagnostics, laboratory automation and IT solutions, urinalysis products, lab testing products, custom biotech solutions, patient self-testing products and solutions for life science.

  • Genetic Testing
  • Spain
  • Direct Sales

Complete report $3,850.  DataPack (test volumes, sales forecasts, supplier shares) $2,500.The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next five years. New specific...

  • Coagulation Diagnostic
  • In Vitro Diagnostic Reagent
  • Laboratory Equipment
  • Monoclonal Antibody
  • Europe
  • Japan
  • United States
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom

The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and AT III testing...

  • Coagulation Diagnostic
  • Laboratory Equipment
  • Monoclonal Antibody
  • Europe
  • Japan
  • United States
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom

The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and D-Dimer testing...

  • Coagulation Diagnostic
  • Laboratory Equipment
  • Monoclonal Antibody
  • Europe
  • Japan
  • United States
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom